Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Society of Interventional Radiology Issues Position Statement to Guide Use of Life-Saving Endovascular Interventions in Trauma Care

“Endovascular intervention plays a critical role in the care of the trauma patient, improving survival, reducing morbidity and decreasing blood loss,” said SIR President Laura Findeiss, MD, FSIR. “When delivered promptly, it is highly effective in treating bleeds throughout the body, including in the liver, spleen, kidneys and pelvis—saving lives and saving function.”

View the full position statement here.

While traumatic injury is the leading cause of death for people younger than 45, the mortality rates have dropped due to better integration of multidisciplinary care, faster access to advanced imaging and interventions, and use of non-operative management in specific scenarios.

“This position statement sets out important recommendations to ensure that the appropriate level of knowledge and expertise are available among all members of the trauma team to ensure that the right care is delivered as swiftly as possible,” Findeiss said.

Among the recommendations offered in the position statement:

  • Immediate 24-hour access to an interventional angiography facility
  • A multidisciplinary team that includes specialists who can perform larger and small vessel endovascular interventions
  • The ability for an interventional team to be ready to intervene within 60 minutes from the time a multidisciplinary team decides to proceed with an endovascular intervention
  • The development and adherence to evidence-based treatment algorithms for each trauma scenario for both adults and children
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy